著者
永井 哲夫 藤野 雅美 若林 類 角田 博之 高森 康次 角田 和之 高木 謙一 中川 種昭 宮岡 等 片山 義郎
出版者
日本歯科心身医学会
雑誌
日本歯科心身医学会雑誌 (ISSN:09136681)
巻号頁・発行日
vol.18, no.1, pp.37-40, 2003

A 53-year old woman complained of a diverse range of symptoms, including sharp pain at the side and root of the tongue, feelings of anxiety, parching, depression, and exhaustion, and early-morning awakening. She had a high score of D on the Minnesota Multiphasic Personality Inventory (MMPI), and was diagnosed as suffering from light depression. Treated with 50mg/day of fluvoxamin, the insomnia was relieved after two weeks, the feelings of depression after four, and all symptoms, including the glossal pain, after eight. The dose was gradually reduced and then stopped altogether after six months. Fluvoxamin is easy to use in the ordinary dental clinical environment because it has almost no anticholinergic effects or cardiovascular side effects. It is thought to show promise for use as a medication for treating a variety of complaints in the oral area.